Bubbled RNA-Based Cargo for Boosting RNA Interference

被引:29
|
作者
Kim, Hyejin [1 ]
Jeong, Jaepil [1 ]
Kim, Dajeong [1 ]
Kwak, Gijung [2 ,3 ]
Kim, Sun Hwa [3 ]
Lee, Jong Bum [1 ]
机构
[1] Univ Seoul, Dept Chem Engn, 163 Seoulsiripdaero, Seoul 02504, South Korea
[2] Korea Univ, KIST Grad Sch Converging Sci & Technol, 145 Anam Ro, Seoul 02841, South Korea
[3] KIST, Biomed Res Inst, Ctr Theragnosis, Seoul 02792, South Korea
来源
ADVANCED SCIENCE | 2017年 / 4卷 / 08期
基金
新加坡国家研究基金会;
关键词
SIRNA DELIVERY; DNA; NANOPARTICLES; NANOTECHNOLOGY; TRANSCRIPTION; OLIGONUCLEOTIDES; MICROSPONGES; THERAPEUTICS; CHALLENGES; GENERATION;
D O I
10.1002/advs.201600523
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
As ribonucleic acid (RNA) nanotechnology has advanced, it has been applied widely in RNA-based therapeutics. Among the range of approaches, enzymatically synthesized RNA structures for inducing RNA interference in cancer cells have potential for silencing genes in a target-specific manner. On the other hand, the efficiency of gene silencing needs to be improved to utilize the RNA-based system for RNAi therapeutics. This paper introduces a new approach for efficient generation of siRNA from bubbled RNA-based cargo (BRC). The presence of bubbles in between to avoid nonfunctional short dsRNAs allows the RNA-based cargoes to contain multiple Dicer-cleavage sites to release the functional siRNAs when introduced to cells. BRCs can be synthesized easily in a one-pot process and be purified by simple centrifugation. Furthermore, efficient target gene silencing by the bubbled structure is confirmed both in vitro and in vivo. Therefore, this bubbled RNA cargo system can be utilized for target-specific RNAi therapeutics with high efficiency in the generation of functional siRNAs in the target cells.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] RNA-based complex coacervates
    Keating, Christine
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
  • [22] RNA-based antiviral immunity
    Shou-Wei Ding
    Nature Reviews Immunology, 2010, 10 : 632 - 644
  • [23] Erratum: RNA-based therapies
    Irena Melnikova
    Nature Reviews Drug Discovery, 2008, 7 (2) : 184 - 184
  • [24] RNA-based antiviral immunity
    Ding, Shou-Wei
    NATURE REVIEWS IMMUNOLOGY, 2010, 10 (09) : 632 - 644
  • [25] The antiquity of RNA-based evolution
    Gerald F. Joyce
    Nature, 2002, 418 : 214 - 221
  • [26] RNA-based viral vectors
    Mogler, Mark A.
    Kamrud, Kurt I.
    EXPERT REVIEW OF VACCINES, 2015, 14 (02) : 283 - 312
  • [27] The antiquity of RNA-based evolution
    Joyce, GF
    NATURE, 2002, 418 (6894) : 214 - 221
  • [28] RNA-Based Therapeutic Technology
    Mashima, Ryuichi
    Takada, Shuji
    Miyamoto, Yoshitaka
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (20)
  • [29] Messenger RNA-based vaccines
    Pascolo, S
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2004, 4 (08) : 1285 - 1294
  • [30] RNA-based methods in virology
    Bradrick, Shelton S.
    Garcia-Blanco, Mariano A.
    METHODS, 2015, 91 : 1 - 2